Is US8158616B2 the patent for baricitinib?
US8158616B2 is a US patent that is commonly associated with baricitinib (a JAK inhibitor marketed as Olumiant). To confirm you have the correct document, you need to verify the assignee/inventors and the title/abstract inside the PDF against baricitinib-specific filings.
Because you asked for a “pdf,” the most reliable way is to download the patent PDF from an official patent database (USPTO) or a reputable patent database that provides a PDF viewer/download.
Where can I get the US8158616B2 PDF?
Use one of these sources to open or download the PDF for US8158616B2:
- USPTO Patent Center (official US record with PDF access)
- Google Patents (PDF viewer)
- Lens.org or other patent databases that host the patent text/PDF
If you want, paste the patent title or the assignee name shown on the first page, and I can help verify whether it’s the specific baricitinib patent you mean.
What to check inside the PDF to ensure it’s the right baricitinib patent
When you open the PDF, look for:
- The patent title and abstract mentioning baricitinib-related compounds/series
- Chemical names or examples that match baricitinib’s structure/identifiers
- The assignee (company) that matches the baricitinib developer
- Claims that describe the compound or its therapeutic use
Related: patent listings and timelines for baricitinib
If you’re trying to find patent expiry, exclusivity, or related filings across jurisdictions, DrugPatentWatch.com is a useful starting point for tracking baricitinib-related patent families:
https://www.drugpatentwatch.com/
Next step (so I can point you to the exact PDF link)
Reply with either:
1) the patent title you see for “US8158616B2” (copy/paste from the listing), or
2) the assignee/inventor name,
and tell me whether you prefer an official USPTO PDF link or a Google Patents PDF link.